Impact of skeletal muscle mass on postoperative complications in oral cancer surgery.
Abstract
[BACKGROUND] Sarcopenia is characterized by a progressive and generalized loss of skeletal muscle mass and strength. The aim of this retrospective study was to investigate the impact of skeletal muscle mass on adverse events in free-flap reconstruction for defects after oral cancer resection.
[RESULTS] Of 120 patients, recipient-site adverse events occurred in 56 patients (46.7%), and recipient-site surgical site infections occurred in 45 patients (37.5%). Skeletal muscle index was significantly associated with recipient-site adverse events in univariate analysis (P < 0.05). Lower body mass index and skeletal muscle index were significantly associated with recipient-site surgical site infection in univariate analysis (P < 0.05). In the multiple logistic regression model, a lower skeletal muscle index was a significant risk factor for recipient-site adverse events and surgical site infections (adverse events odds ratio; 3.17/P = 0.04; surgical site infection odds ratio; 3.76/P = 0.02).
[CONCLUSIONS] The SMI at level Th12 was an independent factor for postoperative AEs, especially SSI, in OSCC patients with free-flap reconstruction.
[RESULTS] Of 120 patients, recipient-site adverse events occurred in 56 patients (46.7%), and recipient-site surgical site infections occurred in 45 patients (37.5%). Skeletal muscle index was significantly associated with recipient-site adverse events in univariate analysis (P < 0.05). Lower body mass index and skeletal muscle index were significantly associated with recipient-site surgical site infection in univariate analysis (P < 0.05). In the multiple logistic regression model, a lower skeletal muscle index was a significant risk factor for recipient-site adverse events and surgical site infections (adverse events odds ratio; 3.17/P = 0.04; surgical site infection odds ratio; 3.76/P = 0.02).
[CONCLUSIONS] The SMI at level Th12 was an independent factor for postoperative AEs, especially SSI, in OSCC patients with free-flap reconstruction.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | flap
|
피판재건술 | dict | 2 | |
| 합병증 | surgical site infection
|
감염 | dict | 2 | |
| 해부 | skeletal muscle
|
scispacy | 1 | ||
| 해부 | muscle
|
scispacy | 1 | ||
| 해부 | skeletal muscle index
|
scispacy | 1 | ||
| 합병증 | ssi
|
감염 | dict | 1 | |
| 약물 | oral cancer
|
C0153381
Malignant neoplasm of mouth
|
scispacy | 1 | |
| 약물 | SMI
|
scispacy | 1 | ||
| 약물 | [BACKGROUND]
|
scispacy | 1 | ||
| 약물 | 3.76/P
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] The
|
scispacy | 1 | ||
| 질환 | skeletal muscle mass
|
C5554793
Skeletal Muscle Mass
|
scispacy | 1 | |
| 질환 | Sarcopenia
|
C0872084
Sarcopenia
|
scispacy | 1 | |
| 질환 | generalized loss of skeletal muscle mass
|
scispacy | 1 | ||
| 질환 | muscle mass
|
C0240417
muscle mass
|
scispacy | 1 | |
| 질환 | oral cancer
|
C0153381
Malignant neoplasm of mouth
|
scispacy | 1 | |
| 질환 | infections
|
C0851162
Infections of musculoskeletal system
|
scispacy | 1 | |
| 질환 | infection
|
C0009450
Communicable Diseases
|
scispacy | 1 | |
| 질환 | lower skeletal muscle
|
scispacy | 1 | ||
| 질환 | OSCC
|
scispacy | 1 | ||
| 질환 | AEs
|
scispacy | 1 | ||
| 질환 | OSCC patients
|
scispacy | 1 | ||
| 기타 | free-flap
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | Th12
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- From Palliation After Angiosarcoma Resection to Totally Autologous Aesthetic Breast Reconstruction Combining Kiss Latissimus Dorsi Flap and Contralateral Breast Sharing Internal Mammary Artery Perforator Flap: A Case Report.
- Case report of a rare soft tissue tuberculosis in a patient undergoing lipoabdominoplasty.
- Otoplasty for prominent ear: A systematic review of surgical techniques.
- Application of the SCIA-Pure Skin Perforator Flap in Bilateral Upper Eyelid Reconstruction: A Case Report and Review of the Literature.